Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
15 participants
INTERVENTIONAL
2006-12-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
NCT02055586
18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
NCT02167204
FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies
NCT00880074
A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00847509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2. Head and neck
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
3. Lung
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
4. prostate
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
5. esophagus
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
1.CNS
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age of 18 or older
* signed informed consent
* being considered for radiotherapy for treatment of CNS mets, Head and neck cancer, lung cancer, prostate cancer or esophageal cancer
Exclusion Criteria
* severe claustrophobia or inability to tolerate PET/CT
* unable to provide written consent
* pregnant or breastfeeding women
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Jeraj, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin Hospital and clinis
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-2006-0280
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.